Cancer Stem Cells

Part of the Cancer Treatment and Research book series (CTAR, volume 154)


Different cancer types have different cancer stem cells owing to their different stem cells of origin.


Stem Cell Progenitor Cell Cancer Stem Cell Chronic Myelogenous Leukemia Normal Stem Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    NOVA PBS science programming on air and online, October 11, 2005. Einstein’s Big Idea. Ancestors of E = mc2. Adapted from Bodanis D (2000) In: E = mc2, biography of the world’s most famous equation. Berkeley Publishing, New YorkGoogle Scholar
  2. 2.
    Lienhard JH (2005) Who invented the telephone? In: Engines of our ingenuity, episode 1098. The University of Houston’s College of Engineering, HoustonGoogle Scholar
  3. 3.
    Stevens LC (1964) Experimental production of testicular teratomas in mice. Proc Natl Acad Sci USA 52:654–661CrossRefPubMedGoogle Scholar
  4. 4.
    Kleinsmith LJ, Pierce GB Jr (1964) Multipotentiality of single embryonal carcinoma cells. Cancer Res 24:1544–1551PubMedGoogle Scholar
  5. 5.
    Pierce GB, Dixon FJ Jr (1959) Testicular teratomas I. Demonstration of teratogenesis by metamorphosis of multipotential cells. Cancer 12:573–583CrossRefPubMedGoogle Scholar
  6. 6.
    Becker AJ, McCulloch EA, Till JE (1963) Cytological demonstration of the clonal nature of spleen colonies derived from transplanted mouse marrow cells. Nature 197:452–454CrossRefPubMedGoogle Scholar
  7. 7.
    Brunschwig A, Southam CM, Levin AG (1965) Host resistance to cancer. Clinical experiments by homotransplants, autotransplants and admixture of autologous leucocytes. Ann Surg 162:416–425CrossRefPubMedGoogle Scholar
  8. 8.
    Hamburger AW, Salmon SE (1977) Primary bioassay of human tumor stem cells. Science 197:461–463CrossRefPubMedGoogle Scholar
  9. 9.
    Bonnet D, Dick JE (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3:730–737CrossRefPubMedGoogle Scholar
  10. 10.
    Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100:3983–3988, Erratum in Proc Natl Acad Sci USA 2003;100 (11):6890CrossRefPubMedGoogle Scholar
  11. 11.
    Singh SK, Hawkins C, Clarke ID et al (2004) Identification of human brain tumour initiating cells [letter]. Nature 432:396–401CrossRefPubMedGoogle Scholar
  12. 12.
    Matsui W, Huff CA, Wang Q et al (2004) Characterization of clonogenic multiple myeloma cells. Blood 103:2332–2336CrossRefPubMedGoogle Scholar
  13. 13.
    Xin L, Lawson DA, Witte ON (2005) The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis. Proc Natl Acad Sci USA 102:6942–6947CrossRefPubMedGoogle Scholar
  14. 14.
    Kim CF, Jackson EL, Woolfenden AE et al (2005) Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121:823–835CrossRefPubMedGoogle Scholar
  15. 15.
    Reya T, Morrison SJ, Clarke MF, Weissman IL (2001) Stem cells, cancer, and cancer stem cells [review]. Nature 414:105–111CrossRefPubMedGoogle Scholar
  16. 16.
    Elhilali MM, Gleave M, Fradet Y et al; The Canadian Urologic Oncologic group (2000) Placebo-associated remissions in a multicentre, randomized, double-blind trial of interferon g-1b for the treatment of metastatic renal cell carcinoma. BJU Int 86:613–618CrossRefPubMedGoogle Scholar
  17. 17.
    Papac RJ (1998) Spontaneous regression of cancer: possible mechanisms [review]. In Vivo 12:571–578PubMedGoogle Scholar
  18. 18.
    Tu S-M, Lopez A, Leibovici D et al (2009) Ductal adenocarcinoma of the prostate: clinical features and implications after local therapy. Cancer 115:2872–2880CrossRefPubMedGoogle Scholar
  19. 19.
    Gunsilius E, Duba H-C, Petzer AL et al (2000) Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow derived endothelial cells. Lancet 355:1688–1691CrossRefPubMedGoogle Scholar
  20. 20.
    Miyamoto T, Weissman IL, Akashi K et al (2000) AML1/ETO-expressing non-leukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation. Proc Natl Acad Sci USA 97:7521–7526CrossRefPubMedGoogle Scholar
  21. 21.
    Radich JP, Dai H, Mao M et al (2006) Gene expression changes associated with progression and response in chronic myeloid leukemia. Proc Natl Acad Sci USA 103:2794–2799CrossRefPubMedGoogle Scholar
  22. 22.
    Cozzio A, Passegué E, Ayton PM et al (2003) Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. Genes Dev 17:3029–3035CrossRefPubMedGoogle Scholar
  23. 23.
    Bachoo RM, Maher EA, Ligon KL et al (2002) Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. Cancer Cell 1:269–277CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.The University of Texas M. D. Anderson Cancer CenterHoustonUSA

Personalised recommendations